登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：600787 证券简称：中储股份 编号：临2025-036号 中储发展股份有限公司关于部分限制性股票回购注销实施公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 回购注销原因：由于《中储发展股份有限公司限制性股票激励计划》（以下简称"《激励计划》"）第 三个解除限售期解除限售条件未成就以及部分激励对象退休原因，根据《上市公司股权激励管理办法》 （以下简称"《管理办法》"）等相关法律、法规、规范性文件以及《激励计划》的相关规定，公司将回 购注销限制性股票共计4,872,998股。 ● 本次注销股份的有关情况 ■ 同日，根据《公司法》等有关法律、法规的规定，公司在中国证券报、上海证券报和上海证券交易所网 站（www.sse.com.cn）发布了《中储发展股份有限公司关于回购注销部分限制性股票通知债权人的公 告》（临2025-032号），自2025年6月20日起45天内，公司未收到相关债权人要求公司提前清偿债务或 者提供相应担保的情况。 二、本次限制 ...

证券代码：600415 证券简称：小商品城 公告编号：临 2025-050 浙江中国小商品城集团股份有限公司 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担个别及连带责任。 一、董事会会议召开情况 （二）审议通过了《关于调整限制性股票回购价格及回购注销部分限制性股 票的议案》 根据《激励计划》的相关规定： （一）本次董事会的召开方式、程序均符合相关法律、法规、规章和《公司 章程》的要求。 （二）本次董事会的会议通知及材料于 2025 年 8 月 4 日以电子邮件、书面材 料等方式送达全体董事。 （三）本次董事会于 2025 年 8 月 14 日下午在浙江省义乌市银海路 567 号商 城集团大厦会议室以现场结合通讯表决方式召开。 （四）本次董事会应出席董事 8 人，实际出席董事 8 人。 （五）本次董事会由董事长陈德占先生主持，公司高管与监事列席了会议。 二、董事会会议审议情况 "激励对象退休而离职的，授予的限制性股票 当年已达到可行使时间限制和业绩考核条件的，可行使部分可在离职之日起的半 年内行使；尚未达到可行使时间限制和业绩考核条件的 ...

Group 1 - The company will cancel the supervisory board and amend the Articles of Association due to the performance assessment of the 2024 restricted stock incentive plan, resulting in the cancellation of 385,920 shares [2] - The company's total share capital will decrease from 235,102,531 shares to 234,716,611 shares, and the registered capital will be adjusted accordingly [2] - The supervisory board's powers will be transferred to the audit committee of the board of directors, and relevant supervisory board regulations will be abolished [2][4] Group 2 - The company will establish and revise several internal systems, including the remuneration management system for directors and senior management, rules for board meetings, and management systems for related party transactions [4] - These internal system changes are in accordance with the Company Law of the People's Republic of China and the revised guidelines for listed companies [4] - The board of directors has approved these proposals, and they are now subject to shareholder review [4]

证券代码：600654 证券简称：中安科 公告编号：2025-065 中安科股份有限公司 关于回购注销部分限制性股票减少注册资本暨通知 债权人的公告 （一）本次拟回购注销 中安科股份有限公司（以下简称"公司"）于 2025 年 8 月 12 日召开公司第 十二届董事会第四次会议，审议并通过了《关于回购注销部分限制性股票的议案》。 鉴于首次授予限制性股票和预留授予限制性股票的共计 9 名激励对象因个 人原因已离职，根据《2023 年股票期权与限制性股票激励计划》 （以下简称"《激 励计划》"）的规定该 9 名激励对象不再具备激励资格，将由公司回购注销该 9 名激励对象已获授未解除限售的 3,481,750 股限制性股票。 上述回购注销事项已得到公司 2023 年第一次临时股东大会的授权，无需提 交公司股东大会审议。限制性股票回购注销事项的具体内容详见公司于 2025 年 （公告编号：2025-064）。 （二）历次回购注销 事会第十二次会议，审议并通过了《关于回购注销部分限制性股票的议案》，拟 回购 2 名已离职的首次授予激励对象的 1,130,000 股限制性股票，公司独立董事 对该事项发表了同意的独立意见， ...

| 证券代码：603567 证券简称：珍宝岛 公告编号：临2025-057 | | | --- | --- | | 黑龙江珍宝岛药业股份有限公司 | | | 关于控股股东权益变动触及 1%刻度的提示性公告 | | | 黑龙江创达集团有限公司保证向本公司提供的信息真实、准确、完整，没有虚假 | | | 记载、误导性陈述或重大遗漏。 | | | 本公司董事会及全体董事保证公告内容与信息披露义务人提供的信息一致。 | | | 重要内容提示： | | | 权益变动方向 比例增加□ 比例减少 | | | 权益变动前合计比例 61.56% | | | 权益变动后合计比例 60.85% | | | 本次变动是否违反已作出的承 | | | 是□ 否 | | | 诺、意向、计划 | | | 是否触发强制要约收购义务 是□ 否 | | | 一、 信息披露义务人及其一致行动人的基本信息 | | | 控股股东/实际控制人及其一致行动人 | | | □合并口径第一大股东及其一致行动人（仅适 投资者及其一致行动人的身份 | | | 用于无控股股东、实际控制人） | | | □其他______________ | | | 信息披露义 | ...

Core Viewpoint - The company has completed the repurchase and cancellation of 4.8594 million restricted stock units from the 2019 second phase incentive plan, which accounts for 1.0674% of the total share capital before the repurchase [1] Summary by Relevant Sections - **Repurchase Details** - The repurchase price was set at 3.48 yuan per share, totaling 16.9107 million yuan [1] - The total share capital of the company has changed from 455 million shares to 450 million shares after the cancellation [1] - **Impact on Financials** - The repurchase and cancellation will not have a significant impact on the company's financial status and operating results [1]

(一)股东大会召开的时间：2025年7月30日 证券代码：600808 证券简称：马钢股份 公告编号：2025-031 马鞍山钢铁股份有限公司 2025年第二次临时股东大会决议公告 马鞍山钢铁股份有限公司（"本公司"或"公司"）董事会及全体董事保证本公告内容不存在任何虚假记 载、误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： ● 本次会议是否有否决议案：无 一、会议召开和出席情况 (二)股东大会召开的地点：安徽省马鞍山市九华西路8号马钢办公楼 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： ■ (四)表决方式符合《公司法》及《公司章程》的规定， 大会由公司董事长蒋育翔先生主持。 (五)公司董事、监事和董事会秘书的出席情况 1、公司在任董事7人，出席7人； 2、公司在任监事3人，出席3人； 3、公司总经理、董事会秘书、副总经理出席本次大会； 4、公司聘请的北京市中伦(上海)律师事务所易菲凡女士、许乐先生出席了本次会议。本次股东大会的 点票监察员由安永华明会计师事务所(特殊普通合伙)担任，蒋昀初先生代表该所出席会议。 二、议案审议情况 (一)非累积投 ...

Core Viewpoint - The company has completed the repurchase and cancellation of part of the restricted stock under the 2023 stock option and restricted stock incentive plan, with a total repurchase amount of RMB 1,836,245.60, resulting in a reduction of the total share capital [1][10][14]. Summary by Sections Stock Incentive Plan Overview - The company approved the 2023 stock option and restricted stock incentive plan on July 10, 2023, and the plan was subsequently authorized by the shareholders' meeting [1][2][3]. - The plan includes performance assessment criteria for the release of restricted stocks, with specific performance targets set for the years 2023 to 2025 [10]. Repurchase and Cancellation Details - The repurchase and cancellation of restricted stocks were conducted due to the failure to meet the performance targets for the year 2024, which required a revenue growth rate of no less than 44% compared to 2022 [10][11]. - The total number of restricted stocks repurchased was 8,400 shares, and the adjusted repurchase price was set at RMB 5.56 per share [12][14]. Changes in Share Capital Structure - Following the repurchase, the company's share capital structure changed, with the number of restricted shares with limited sale conditions decreasing from 24,243,087 to 23,912,827 shares [14]. - The total number of shares after the repurchase is 867,357,451 shares, maintaining compliance with listing requirements [14]. Financial Impact - The repurchase and cancellation of restricted stocks will not have a substantial impact on the company's financial status or operational results, nor will it affect the ongoing implementation of the incentive plan [14].

Core Viewpoint - The company, Heilongjiang Zhenbaodao Pharmaceutical Co., Ltd., is implementing a buyback and cancellation of 144,094 restricted stocks due to the departure of three employees, which represents 5.95% of the total stock under the incentive plan and 0.02% of the company's total share capital [1][2]. Group 1: Buyback and Cancellation Details - The buyback and cancellation are based on the provisions of the "Incentive Plan" and the "Management Measures for Equity Incentives of Listed Companies," which stipulate that restricted stocks cannot be released from restrictions if the employee has left the company [2][3]. - The total amount for the buyback is 1,186,181.80 yuan, sourced from the company's own funds [2][3]. - The cancellation of the stocks is expected to be completed by July 29, 2025, with the company having opened a dedicated securities account for this purpose [3]. Group 2: Impact on Share Capital Structure - Following the cancellation, the company's total share capital will decrease from 941,140,609 shares to 940,996,515 shares [3][4]. - The cancellation will not affect the controlling shareholder or the actual controller, and the company's equity distribution will still meet the listing requirements [4]. Group 3: Legal Compliance and Commitments - The board of directors confirmed that the decision-making process and information disclosure comply with relevant laws and regulations, ensuring no harm to the rights of the incentive objects or creditors [4][5]. - The company has committed to handling any disputes arising from this buyback and cancellation responsibly [4][5].

Core Viewpoint - Shenzhen Suoling Industrial Co., Ltd. plans to repurchase and cancel 400,000 restricted stocks at a price of 2.60 RMB per share due to the departure of one incentive object under the 2023 incentive plan [10][12]. Group 1: Repurchase and Cancellation Details - The repurchase involves 400,000 restricted stocks that have been granted but not yet released from the lock-up period [10]. - The repurchase price is set at 2.60 RMB per share, which aligns with the granting price specified in the incentive plan [10]. - The decision to repurchase has been approved by the company's board and supervisory committee [10][12]. Group 2: Legal Compliance and Opinions - The legal opinion confirms that the repurchase and cancellation comply with relevant laws, including the Company Law and Securities Law [10][12]. - The law firm has conducted thorough verification of the facts and documents related to the incentive plan and has concluded that the repurchase is legitimate and authorized [2][10]. - The company is required to continue fulfilling its information disclosure obligations as the incentive plan progresses [12].